International Psoriasis Council

Advancing Knowledge. Enhancing Care.

Advancing Knowledge. Enhancing Care.

New Corporate Member

new corporate member anaptysbio

The International Psoriasis Council is pleased to welcome AnaptysBio as a 2022 Bronze Level Corporate Member. AnaptysBio, based in San Diego, California, is a clinical-stage biotechnology company developing first-in-class immunology therapeutic product candidates for patients. They are focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. “We are extremely pleased to welcome AnaptysBio to the IPC family and look forward to working with them to improve the care of people with psoriasis worldwide through education, research, and advocacy,” said IPC CEO Christy Langan.

Learn more about AnaptysBio.

Categories
Recent Posts
Almirall Press Release Graphic

Happify Health and Almirall Partner Together to Launch Claro

022 SID Congress Report Blog Graphic

Focus on Psoriasis: A Report from the 2022 Society for Investigative Dermatology (SID) Annual Meeting

Lilly Press Release Graphic

Lilly Announces a New, Citrate-Free Formulation of Taltz® (ixekizumab)

Also Read

councilors

New IPC Councilor

Dr. Claus Johansen joins the group of IPC experts who are working to advance knowledge and enhance the care psoriasis patients around the world.

Read More
psoprotect_update_615
registries

PsoProtect Registry Data Update

PsoProtect, a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data and now includes the first 1,652 cases.

Read More
councilors

Newest IPC Councilors

Three councilors join the group of IPC experts who are working to advance knowledge and enhance the care psoriasis patients around the world.

Read More

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.